Literature DB >> 16599946

Behavioural and histopathological alterations in mice with cerebral malaria.

P Lackner1, R Beer, V Heussler, G Goebel, D Rudzki, R Helbok, E Tannich, E Schmutzhard.   

Abstract

Different features of sensorimotor function and behaviour were studied in murine cerebral malaria (CM) and malaria without cerebral involvement (non-CM) applying the primary screen of the SHIRPA protocol. Histopathological analysis of distinct brain regions was performed and the relative size of haemorrhages and plugging of blood cells to brain vasculature was analysed. Animals suffering from CM develop a wide range of behavioural and functional alterations in the progressive course of the disease with a statistically significant impairment in all functional categories assessed 36 h prior to death when compared with control animals. Early functional indicators of cerebral phenotype are impairments in reflex and sensory system and in neuropsychiatric state. Deterioration in function is paralleled by the degree of histopathological changes with a statistically significant correlation between the SHIRPA score of CM animals and the mean size of brain haemorrhage. Furthermore, image analysis yielded that the relative area of the brain lesions was significantly larger in the forebrain and brainstem compared with the other regions of interest. Our results indicate that assessment of sensory and motor tasks by the SHIRPA primary screen is appropriate for the early in vivo discrimination of cerebral involvement in experimental murine malaria. Our findings also suggest a correlation between the degree of functional impairment and the size of the brain lesions as indicated by parenchymal haemorrhage. Applying the SHIRPA protocol in the functional characterization of animals suffering from CM might prove useful in the preclinical assessment of new antimalarial and potential neuroprotective therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16599946     DOI: 10.1111/j.1365-2990.2006.00706.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  63 in total

1.  Cerebral tissue oxygenation impairment during experimental cerebral malaria.

Authors:  Pedro Cabrales; Yuri C Martins; Peng Kai Ong; Graziela M Zanini; John A Frangos; Leonardo J M Carvalho
Journal:  Virulence       Date:  2013-09-11       Impact factor: 5.882

Review 2.  Endothelin-1 and its role in the pathogenesis of infectious diseases.

Authors:  Brandi D Freeman; Fabiana S Machado; Herbert B Tanowitz; Mahalia S Desruisseaux
Journal:  Life Sci       Date:  2014-04-26       Impact factor: 5.037

3.  In Vivo Function of PTEX88 in Malaria Parasite Sequestration and Virulence.

Authors:  Joachim M Matz; Alyssa Ingmundson; Jean Costa Nunes; Werner Stenzel; Kai Matuschewski; Taco W A Kooij
Journal:  Eukaryot Cell       Date:  2015-03-27

4.  Efficacy of proveblue (methylene blue) in an experimental cerebral malaria murine model.

Authors:  Jérome Dormoi; Sébastien Briolant; Camille Desgrouas; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2013-04-22       Impact factor: 5.191

5.  Algorithms to predict cerebral malaria in murine models using the SHIRPA protocol.

Authors:  Yuri C Martins; Guilherme L Werneck; Leonardo J Carvalho; Beatriz P T Silva; Bruno G Andrade; Tadeu M Souza; Diogo O Souza; Cláudio T Daniel-Ribeiro
Journal:  Malar J       Date:  2010-03-24       Impact factor: 2.979

6.  Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy.

Authors:  Patricia A Reis; Clarissa M Comim; Fernanda Hermani; Bruno Silva; Tatiana Barichello; Aline C Portella; Flavia C A Gomes; Ive M Sab; Valber S Frutuoso; Marcus F Oliveira; Patricia T Bozza; Fernando A Bozza; Felipe Dal-Pizzol; Guy A Zimmerman; João Quevedo; Hugo C Castro-Faria-Neto
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

7.  A rapid murine coma and behavior scale for quantitative assessment of murine cerebral malaria.

Authors:  Ryan W Carroll; Mark S Wainwright; Kwang-Youn Kim; Trilokesh Kidambi; Noé D Gómez; Terrie Taylor; Kasturi Haldar
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

8.  Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Authors:  Colette Cywes-Bentley; David Skurnik; Tanweer Zaidi; Damien Roux; Rosane B Deoliveira; Wendy S Garrett; Xi Lu; Jennifer O'Malley; Kathryn Kinzel; Tauqeer Zaidi; Astrid Rey; Christophe Perrin; Raina N Fichorova; Alexander K K Kayatani; Tomas Maira-Litràn; Marina L Gening; Yury E Tsvetkov; Nikolay E Nifantiev; Lauren O Bakaletz; Stephen I Pelton; Douglas T Golenbock; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  Distinct Prominent Roles for Enzymes of Plasmodium berghei Heme Biosynthesis in Sporozoite and Liver Stage Maturation.

Authors:  Zaira Rizopoulos; Kai Matuschewski; Joana M Haussig
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

10.  Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.

Authors:  Peter Lackner; Andrea Part; Christoph Burger; Anelia Dietmann; Gregor Broessner; Raimund Helbok; Markus Reindl; Erich Schmutzhard; Ronny Beer
Journal:  Malar J       Date:  2009-02-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.